News / Health

Test of New Dengue Vaccine Shows Promise

A boy with dengue fever receives medical oxygen while laying on a bed at the Quirino hospital in Quezon city in the suburbs of Manila, August 14, 2012.A boy with dengue fever receives medical oxygen while laying on a bed at the Quirino hospital in Quezon city in the suburbs of Manila, August 14, 2012.
x
A boy with dengue fever receives medical oxygen while laying on a bed at the Quirino hospital in Quezon city in the suburbs of Manila, August 14, 2012.
A boy with dengue fever receives medical oxygen while laying on a bed at the Quirino hospital in Quezon city in the suburbs of Manila, August 14, 2012.
Faith Lapidus
A clinical trial of a new vaccine against dengue fever shows progress toward fighting the most common mosquito-borne disease.  The drug is less successful than hoped, but seems to be effective at preventing three of the four related viruses that cause dengue.

Dengue fever increasing

Dengue fever is endemic across the tropics, with more than 2.5 billion people in 128 countries at risk. Symptoms can range from aches and fever to circulatory failure, coma and death.  Some 21,000 people die of dengue each year, and the number of cases is increasing, including outbreaks in the southeastern United States.

There is no vaccine available to prevent dengue fever.  Part of the difficulty in developing one is that there are four different but related types of the disease.  Those who recover from infection by one type gain lifetime immunity, but only against that type.  Scott Halstead, of the Dengue Vaccine Initiative, explains that they are still at risk of infection with one of the other types.

"Dengue normally produces a short acute febrile disease, sort of a flu-like disease which ends in a rash, and when you're convalescent, you have life-long immunity to the type you've been infected with, say Type 1.  But you are susceptible then to either type 2 or 3 or 4, and what we've learned is that two different infections - with say, Type 1 and Type 2 - can result in a very severe catastrophic disease called dengue hemorrhagic fever, and this occurs all over the tropical world, mostly in Asia and the American tropics," Halstead explained.

New vaccine

That is why researchers are focused on developing a so-called tetravalent vaccine, modeled on the successful yellow fever vaccine, combining weakened versions of all four types of dengue virus into a single drug. 

Halstead, who was not involved in the new clinical trial, says the pharmaceutical company, Sanofi Pasteur, took a molecular approach to creating its vaccine.

"They actually spliced the gene for each of the four dengue viruses into a yellow fever backbone.  So this is a combined vaccine called a chimera, combining the yellow fever replicative machinery and the dengue surface proteins," he said. "But it is a vaccine mixture of dengue 1, 2, 3 and 4."

In the first trial to determine whether a vaccine could actually prevent the disease, Sanofi's drug was tested in 4,000 school children in Thailand.  The children got three doses of either the vaccine or a placebo.  Spacing the shots six months apart was meant to mimic the natural immune response people develop over time.  Two years later, the vaccine seemed to have protected the children against three of the four strains, but not the most common type of the virus, which accounts for about 40 percent of severe dengue cases worldwide.

But the results show that the vaccine is safe, and technologically possible.

Although Halstead and many other dengue experts expressed disappointment that Sanofi's vaccine was not more effective, they regard it as an important step forward.

"The problem is, can we use a vaccine that only protects against three?  In my commentary that I wrote for The Lancet, I speculated that maybe, if you could really give enough of a three-component vaccine to stop transmission, you'd actually leave just one virus, and one virus all by itself won't cause dengue hemorrhagic fever.  So a lot of the really serious problems caused by dengue viruses might be controlled with a three-component vaccine," said Halstead.

Sanofi is already testing its new vaccine in large Phase 3 trials involving more than 30,000 people in 10 countries, with results expected in 2014.  A report about the Phase 2 trial, and Dr. Halstead's commentary, appear in the medical journal, The Lancet.

You May Like

Video Five Patients Given Experimental Ebola Drug Said To Be Improving

Experimental drugs have been tried on six people: three Westerners and now, three African pyhysicians More

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As Ukrainian military reclaims control of eastern cities residents rebuild their lives, but many say everyone is being treated with suspicion More

Video In Rural Kenya, Pressure Builds Against Female Circumcision

Girls learn to object; FGM practitioners face penalties from jail sentences to stiff fines More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Five Patients Given Experimental Ebola Drug Said to Be Improvingi
X
Carol Pearson
August 19, 2014 11:43 PM
The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video Five Patients Given Experimental Ebola Drug Said to Be Improving

The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As the Ukrainian military reclaims control of eastern cities from pro-Russian separatists, residents are getting a chance to rebuild their lives. VOA's Gabe Joselow reports from the town of Kramatorsk in Donetsk province, where a sense of fear is still in the air, and distrust of the government in Kyiv still runs deep.
Video

Video China Targets Overseas Assets of Corrupt Officials

As China presses forward with its anti-graft effort, authorities are targeting corrupt officials who have sent family members and assets overseas. The efforts have stirred up a debate at home on exactly how many officials take that route and how likely it is they will be caught. Rebecca Valli has this report.
Video

Video Leading The Fight Against Islamic State, Kurds Question Iraqi Future

Western countries including the United States have begun arming the Kurdish Peshmerga forces in northern Iraq to aid their battle against extremist Sunni militants from the Islamic State. But there are concerns that a heavily-armed Kurdistan Regional Government, or KRG, might seek to declare independence and cause the break-up of the Iraqi state. As Henry Ridgwell reports from London, the KRG says it will only seek greater autonomy from Baghdad.
Video

Video In Rural Kenya, Pressure Builds Against Female Circumcision

In some Kenyan communities, female genital mutilation remains a rite of passage. But activists are pushing back, with education for girls and with threats of punishment those who perform the circumcision. Mohammed Yusuf looks at the practice in the rural eastern community of Tharaka-Nithi.
Video

Video For Obama, Racial Violence is Personal Issue

The racial violence in the St. Louis suburb of Ferguson is presenting U.S. President Barack Obama with an issue to which he has a deep personal connection. To many Americans, Obama's election as America's first black president marked a turning point in race relations in the United States, and Obama has made ending the violence a policy priority. On Monday he issued a new call for calm and understanding. Luis Ramirez reports from the White House.
Video

Video Clinton-Obama Relationship Could Impact 2016 Election

President Barack Obama and former Secretary of State Hillary Clinton have a long and complicated relationship. That relationship took another turn recently when Clinton criticized the president’s foreign policy. VOA National Correspondent Jim Malone reports there is renewed attention on the Clinton-Obama relationship as Hillary Clinton considers running for
Video

Video Iran Looks to Maintain Influence in Baghdad With New Shia PM

Washington and Tehran share the goal of stopping Syrian-based militants in Iraq. But experts say it's Iran, not the United States, that will most influence how the new government in Baghdad approaches internal reforms and the war in Syria. VOA State Department Correspondent Scott Stearns has the story.

AppleAndroid